American Heart Journal
Volume 152, Issue 1 , Pages 93.e1-93.e6 , July 2006

Aortic stiffness correlates with an increased extracellular matrix turnover in patients with dilated cardiomyopathy

Received 9 November 2005 ,Accepted 13 April 2006.

References 

  1. Pepine CJ, Nichols WW, Conti CR. Aortic input impedance in heart failure. Circulation. 1978;58:460–465
  2. Arnold JMO, Marchiori GE, Imrie JR, et al. Large artery function in patients with chronic heart failure. Circulation. 1991;84:2418–2425
  3. Carroll JD, Shroff S, Wirth P, et al. Arterial mechanical properties in dilated cardiomyopathy. J Clin Invest. 1991;87:1002–1009
  4. Bonapace S, Rossi A, Cicoira M, et al. Aortic distensibility independently affects exercise tolerance in patients with dilated cardiomyopathy. Circulation. 2003;107:1603–1608
  5. Giannattasio C, Achilli F, Failla M, et al. Radial, carotid and aortic distensibility in congestive heart failure: effects of high-dose angiotensin-converting enzyme inhibitor or low-dose association with angiotensin type 1 receptor blockade. J Am Coll Cardiol. 2002;39:1275–1282
  6. Nichols WW, O'Rourke MF. Vascular impedance. In: McDonald's blood flow in arteries: theoretical, experimental and clinical principles. 4th ed. London (UK): Edward Arnold. 1998:54-97, 243-83, 347-95.
  7. Dobrin PB, Baker WH, Gley WC. Elastolytic and collagenolytic studies of arteries. Implications for the mechanical properties of aneurysms. Arch Surg. 1984;119:405–409
  8. McCullagh KG, Duance VC, Bishop KA. The distribution of collagen types I, III and V (AB) in normal and atherosclerotic human aorta. J Pathol. 1980;130:45–55
  9. Risteli L, Risteli J. Noninvasive methods for detection of organ fibrosis. In:  Rojkind M editors. Focus on connective tissue in health and disease. Boca Raton (Fla): CRC Press; 1990;p. 61–98
  10. Klappacher G, Franzen P, Haab D, et al. Measuring extracellular matrix turnover in the serum of patients with idiopathic and ischemic dilated cardiomyopathy and impact on diagnosis and prognosis. Am J Cardiol. 1995;75:913–918
  11. Zannad F, Alla F, Dousset B, et al. Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure. Circulation. 2000;102:2700–2706
  12. Diez J, Laviades C, Mayor G, et al. Increased serum concentrations of procollagen peptides in essential hypertension. Relation to cardiac alterations. Circulation. 1995;91:1450–1456
  13. Uusimaa P, Risteli J, Niemela M, et al. Collagen scar formation after acute myocardial infarction: relationships to infarct size, left ventricular function, and coronary artery patency. Circulation. 1997;96:2565–2572
  14. Cicoira M, Rossi A, Bonapace S, et al. Independent and additional prognostic value of aminoterminal propetide of type III procollagen circulating levels in patients with chronic heart failure. J Card Fail. 2004;10:403–411
  15. Duprez DA, De Buyzere ML, Rietzschel ER, et al. Inverse relationship between aldosterone and large artery compliance in chronically treated heart failure patients. Eur J Heart. 1998;19:1371–1376
  16. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium: fibrosis and renin-angiotensin-aldosterone system. Circulation. 1991;83:1849–1865
  17. Sun Y, Ramires FJ, Weber KT. Fibrosis of atria and great vessels in response to angiotensin II or aldosterone infusion. Cardiovasc Res. 1997;35:138–147
  18. Park JB, Schiffrin EL. Cardiac and vascular fibrosis and hypertrophy in aldosterone infused rats: role of endothelin-1. Am J Hypertens. 2002;15:164–169
  19. Albaladejo P, Bouaziz H, Duriez M, et al. Angiotensin converting enzyme inhibition prevents the increase in aortic collagen in rats. Hypertension. 1994;23:74–82
  20. Benetos A, Lacolley P, Safar ME. Prevention of aortic fibrosis by spironolactone in spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol. 1997;17:1152–1156
  21. Lacolley P, Safar ME, Lucet B, et al. Prevention of aortic and cardiac fibrosis by spironolactone in old normotensive rats. J Am Coll Cardiol. 2001;37:662–667
  22. Hundley WG, Kitzman DW, Morgan TM, et al. Cardiac cycle-dependent changes in aortic area and distensibility are reduced in older patients with isolated diastolic heart failure and correlate with exercise intolerance. J Am Coll Cardiol. 2001;38:796–801
  23. Baguet JP, Kingwell BA, Dart AL, et al. Analysis of the regional pulse wave velocity by Doppler: methodology and reproducibility. J Hum Hypertens. 2003;17:407–412
  24. Sullivan DR, Marwick TH, Freedman SB. A new method of scoring coronary angiograms to reflect extent of coronary atherosclerosis and improve correlation with major risk factors. Am Heart J. 1990;119:1262–1267
  25. Ramsey MW, Goodfellow J, Jones CJ, et al. Endothelial control of arterial distensibility is impaired in chronic heart failure. Circulation. 1995;92:3212–3219
  26. Levine TB, Francis CS, Goldsmith SR, et al. Activity of the sympathetic nervous system renin-angiotensin system assessed by plasma hormone levels and their relationships to hemodynamic abnormalities in congestive heart failure. Am J Cardiol. 1982;49:1659–1666
  27. Guerin AP, Blacher J, Pannier B. Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation. 2001;103:987–992
  28. Medley TL, Cole TJ, Gatzka CD, et al. Fibrillin-1 genotype is associated with aortic stiffness and disease severity in patients with coronary artery disease. Circulation. 2002;105:810–815
  29. Lombes M, Oblin ME, Gasc JM, et al. Immunohistochemical and biochemical evidence of a cardiovascular mineralcorticoid receptor. Circ Res. 1992;71:503–510
  30. Zelis R, Delea CS, Coleman HN, et al. Arterial sodium content in experimental congestive heart failure. Circulation. 1970;41:213–216
  31. Safar ME, Thuilliez C, Richard V, et al. Pressure–independent contribution of sodium to large artery structure and function in hypertension. Cardiovasc Res. 2000;46:269–276
  32. Bryant D, Becker L, Richardson J, et al. Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor–alpha. Circulation. 1998;97:1340–1341
  33. Lacolley P, Labat C, Pujol A, et al. Increased carotid wall elastic modulus and fibronectin in aldosterone-salt-treated rats: effects of eplerenone. Circulation. 2002;106:2848–2853
  34. Pitt B, Remme W, Zannad F, et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 2003;348:1309–1321
  35. Medley TL, Kingwell BA, Gatzka CD, et al. Matrix metalloproteinase-3 genotype contributes to age-related aortic stiffening through modulation of gene and protein expression. Circ Res. 2003;92:1254–1261

PII: S0002-8703(06)00396-6

doi: 10.1016/j.ahj.2006.04.026

American Heart Journal
Volume 152, Issue 1 , Pages 93.e1-93.e6 , July 2006

Article Tools

* Image Usage & Resolution